Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    " February 03, 2010":" March 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
22 Completed Stocrin Re-examination Study (0831-028)
Condition: HIV Infection
Intervention:
23 Completed
Has Results
Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim
24 Completed GSK1349572 Drug Interaction Study With Efavirenz
Conditions: Infections, Human Immunodeficiency Virus and Herpesviridae;   Healthy
Interventions: Drug: GSK1349572;   Drug: Efavirenz
25 Completed Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: GSK1349572
26 Completed Observational Data Analysis in EuroSIDA (0518-058)
Condition: HIV-1 Infections
Intervention:
27 Completed A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Minocycline
28 Completed Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Condition: HIV Infections
Interventions: Drug: darunavir/ritonavir QD + raltegravir BID;   Drug: darunavir/r QD + tenofovir/emtricitabine QD (fixed dose combination)
29 Completed Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
Conditions: HIV;   HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
30 Active, not recruiting Post-Licensure Safety Study of ISENTRESS™ in a US Managed Care Network (MK-0518-268)
Condition: HIV-1 Infections
Intervention:
31 Completed Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)
Condition: HIV Infection
Intervention:
32 Active, not recruiting Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Condition: HIV Infection
Interventions: Biological: AGS-004;   Biological: Placebo
33 Completed Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection
Condition: HIV Infection
Intervention: Biological: blood test at day one
34 Active, not recruiting Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil fumarate (TDF)
35 Completed Surveillance of Kaletra in Korean Patients
Condition: HIV-1 Infection
Intervention:
36 Completed
Has Results
Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China
Condition: HIV-1 Infections
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
37 Completed Improving Sleep and Quality of Life in Adults With HIV Disease
Condition: Insomnia
Interventions: Behavioral: Music Therapy;   Behavioral: Yoga
38 Completed Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting
Condition: Substance Use
Intervention:
39 Active, not recruiting Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
Condition: Kaposi's Sarcoma
Intervention: Drug: Indinavir in association with Vinblastina +/- Bleomicina

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years